- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lucid Diagnostics Inc (LUCD)
Lucid Diagnostics Inc stock price live, this page displays NASDAQ LUCD stock exchange data. View the LUCD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lucid Diagnostics Inc real time stock price chart below.
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 1.3300.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock ticker symbol for Lucid Diagnostics Inc is LUCD.
Is LUCD the Same as $LUCD?
$LUCD is a common way to refer to the Lucid Diagnostics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lucid Diagnostics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
What Is the Lucid Diagnostics Inc Stock Price Today?
The Lucid Diagnostics Inc stock price today is 1.3300.
What Is the Stock Symbol for Lucid Diagnostics Inc?
The stock ticker symbol for Lucid Diagnostics Inc is LUCD.
Is LUCD the Same as $LUCD?
$LUCD is a common way to refer to the Lucid Diagnostics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lucid Diagnostics Inc Trade On?
Lucid Diagnostics Inc is listed and trades on the NASDAQ stock exchange.
Is Lucid Diagnostics Inc a Good Stock to Buy?
Determining whether Lucid Diagnostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lucid Diagnostics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUCD quote. (ISIN: US54948X1090)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.2100
1.3300
52 wk Range
0.9495
1.8000
Earnings results expected in 10 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.21001.3300
52 wk Range
0.94951.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LUCD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.7917
Upside
+185.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Lucid Diagnostics Inc Company Profile
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc SWOT Analysis
Analyst Outlook | Price targets range from $2.00 to $7.50, reflecting mixed sentiment on Lucid's prospects amid recent test volume fluctuations and revenue challenges |
Financial Hurdles | Despite 40% revenue growth, Lucid faces profitability challenges with negative margins and cash burn, highlighting the importance of securing reimbursement |
Reimbursement Quest | The company nears a crucial Medicare coverage milestone for EsoGuard, which could transform its business model from volume-focused to revenue-driven |
Market Potential | Lucid Diagnostics targets a $25 billion BE-EAC screening market in the US, positioning its EsoGuard/EsoCheck offerings as potential industry standards |
Lucid Diagnostics Inc Earnings Call Summary for Q3/2025
- Lucid Diagnostics (LUCD) reported Q3 2025 revenue of $1.2 million, up 3% year-over-year, with 2,841 tests conducted and a post-earnings stock price increase of 1.92% to $1.04.
- The company raised approximately $27 million through a public offering, bolstering cash reserves to $47.3 million against a quarterly burn rate of $10.3 million.
- Strategic focus centers on Medicare patient targeting, with the company preparing for a draft Medicare Local Coverage Determination by end-2025 that could expand market reach to 50 million patients.
- CEO Dr. Lishan Aklog expressed confidence in Medicare coverage approval, stating 'It's not a matter of if. It's a matter of when,' while acknowledging the need for fiscal discipline.
- Ongoing NIH and VA studies aim to expand the diagnostic test's target population, with the company exploring cost reduction through automation and AI implementation.
Last Updated: 11/12/2025, 10:19 AM
Read Full TranscriptCompare LUCD to Peers and Sector
Metrics to compare | LUCD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUCDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −0.2x | −0.5x | |
PEG Ratio | −0.09 | 0.22 | 0.00 | |
Price / Book | −6.4x | 1.2x | 2.6x | |
Price / LTM Sales | 41.6x | 1.9x | 3.3x | |
Upside (Analyst Target) | 126.4% | 58.7% | 47.0% | |
Fair Value Upside | Unlock | 24.3% | 6.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.7917
(+185.09% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.10 / -0.11
Revenue / Forecast
1.21M / 1.36M
People Also Watch
FAQ
What Is the Lucid Diagnostics (LUCD) Stock Price Today?
The Lucid Diagnostics stock price today is 1.3300
What Stock Exchange Does Lucid Diagnostics Trade On?
Lucid Diagnostics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Lucid Diagnostics?
The stock symbol for Lucid Diagnostics is "LUCD."
What Is the Lucid Diagnostics Market Cap?
As of today, Lucid Diagnostics market cap is 183.1200M.
What Is Lucid Diagnostics's Earnings Per Share (TTM)?
The Lucid Diagnostics EPS (TTM) is -0.79.
When Is the Next Lucid Diagnostics Earnings Date?
Lucid Diagnostics will release its next earnings report on Feb 24, 2026.
From a Technical Analysis Perspective, Is LUCD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lucid Diagnostics Stock Split?
Lucid Diagnostics has split 0 times.
How Many Employees Does Lucid Diagnostics Have?
Lucid Diagnostics has 72 employees.
What is the current trading status of Lucid Diagnostics (LUCD)?
As of Feb 14, 2026, Lucid Diagnostics (LUCD) is trading at a price of 1.3300, with a previous close of 1.2200. The stock has fluctuated within a day range of 1.2100 to 1.3300, while its 52-week range spans from 0.9495 to 1.8000.
What Is Lucid Diagnostics (LUCD) Price Target According to Analysts?
The average 12-month price target for Lucid Diagnostics is USD3.7917, with a high estimate of USD8.25 and a low estimate of USD2.5. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +185.09% Upside potential.
What Is the LUCD Premarket Price?
LUCD's last pre-market stock price is 1.2201. The pre-market share volume is 1,110.0000, and the stock has decreased by 0.0001, or 0.0100%.
What Is the LUCD After Hours Price?
LUCD's last after hours stock price is 1.3108, the stock has decreased by -0.0192, or -1.4400%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.